Results
Johnson & Johnson
09/11/2024 | Press release | Distributed by Public on 09/11/2024 16:24
TREMFYA® (guselkumab) receives U.S. FDA approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson's leadership in inflammatory[...]
Sharing and Personal Tools
Please select the service you want to use:
Smartlinks | Johnson & Johnson | News | Health | Science | Research | Politics and Policy | Policy and Regulation | Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Securities Issuers | Pharmaceutical Companies | Borsa Italiana | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Santiago Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | Lima Stock Exchange (BVL) | Moscow Exchange (MOEX) | PFTS Ukraine Stock Exchange | Colombia Securities Exchange | Kazakhstan Stock Exchange (KASE) | Bulgarian Stock Exchange | BX Swiss | Ukrainian Exchange | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Bolsa Electrónica de Chile | Cboe Canada | Cboe BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Aquis Exchange | Investors Exchange (IEX) | Omega ATS | Lynx ATS | SIGMA X MTF | EuroTLX | Bolsa Institucional de Valores (BIVA) | Aquis Exchange Europe | Equiduct | Hannover Stock Exchange | Nasdaq BX | Nasdaq CX2 | Nasdaq CXC | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact